LobbyingOrtho Molecular Products lobbying by quarter
Ortho Molecular Products's latest lobbying report covers Q3 2023, at $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Ortho Molecular Products
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues2 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Prairie Road | $40K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/09/22for Q3 2023 | Prairie Road | $10K |
| 23/07/18for Q2 2023 | Prairie Road | $10K |
| 23/05/03for Q1 2023 | Prairie Road | $10K |
| 23/01/20for Q4 2022 | Prairie Road | $10K |